1Yeo CJ, Cameron JL. The pancreas[A]. In: Sabiston DC, ed. Sabiston textbook of surgery, the biological basis of modern surgical practice[M]. 15th ed. Philadelphia: WB Saunders Company, 1997. 1152-1153.
2Howard TJ, Stonerock CE, Sarkar J, et al. Contemporary treatment strategies for external pancreatic fistulas[J]. Surgery, 1998, 124(4):627-632.
3Cullen JJ, Sarr MG, Ilstrup DM. Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management[J]. Am J Surg, 1994,168(4):295-298.
4Sitges-Serra A, Jaurrieta E, Sitges-Creus A. Management of postoperative enterocutaneous fistulas: the roles of parenteral nutritiom and surgery[J]. Br J Surg, 1982,69(3):147-150.
5Aston SJ, Longmire WP Jr. Management of the pancreas after pancreaticoduodenectomy[J]. Ann Surg, 1974,179(3):322-327.
6马青年,姚泰主编. 生理学[M]. 北京:人民卫生出版社,2001. 375-377.
7Grosman I, Simon D. Potential gastrointestinal uses of somatostain and its synthetic analogue octreotide[J]. Am J Gastroenterol, 1990,85(9):1061-1072.
8Evers BM, Parekh D, Townsend CM Jr, et al. Somatostatin and analogues in the treatment of cancer. A review[J]. Ann Surg, 1991,213(3):190-198.
9Pederzoli P, Bassi C, Falconi M, et al. Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin[J]. Surg Gynecol Obstet, 1986,163(5):428-432.
10Rosenberg L, Dafoe DC, Schwartz R, et al. Administration of somatostatin analog (SMS 201-995) in the treatment of a fistula occurring after pancreas transplantation. Interference with cyclosporine immunosuppression[J]. Transplantation, 1987,43(5):764-766.
24，Kill J,Ronning H.Pancreatic fistula cured by an endoprosthesis in the pancreaticduct.Br J Surg，1993，80:1316.
35，Pedrzoli P,Bassi C,Falconi M.Efficacy of octreotide in the prevention of complicationsof electiye pencreatic surgrey.Br J Surg，1994,81:265～269.
(收稿： 2000-02-12)
3Peretz T,Nori D,Hilaris B,et al.Treatment of primary unresectable carcinoma of the pancreas with I-125 implantation[J].Int J Radiat Oncol Biol Phys,1989,17(5):931-935.
4Burris HA,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial[J].J Clin Oncol,1997,15(6):2403-2413.
5Grunewald R,Abbruzzese JL,Tarassoff P,et al.Saturation of 2,2-difluorodeoxycytidine 5-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine[J].Cancer Chemother Pharmacol,1991,27(4):258-262.
